The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction

The modified Glasgow Prognostic Score (mGPS) combines the indicators of decreased plasma albumin and elevated CRP. In a number of malignancies, elevated mGPS is associated with poor survival. Aim of this study was to investigate the prognostic role of mGPS in patients with neoadjuvantly treated aden...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Jomrich, Gerd, Hollenstein, Marlene, John, Maximilian, Baierl, Andreas, Paireder, Matthias, Kristo, Ivan, Ilhan-Mutlu, Aysegül, Asari, Reza, Preusser, Matthias, Schoppmann, Sebastian F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2018
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805529/
https://ncbi.nlm.nih.gov/pubmed/29467943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24087
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky